Online Support for Families with Heart Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a virtual program called I-InTERACT-North to determine if it can help parents improve their skills and positively influence their child's behavior. It targets families with children aged 3 to 9 born with congenital heart disease (a heart condition present at birth). The study aims to assess the program's usefulness and ease of use for these families. Ideal participants are parents of children with this condition who are patients at SickKids in Ontario. As an unphased trial, this study provides families the chance to contribute to innovative research that could enhance support for children with congenital heart disease.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It focuses on a mental health program for parents, so it's unlikely that medication changes are required.
What prior data suggests that the I-InTERACT-North program is safe for families with children born with Congenital Heart Disease?
Research has shown that the I-InTERACT-North program is a well-received online tool for helping parents. This virtual program aims to improve parenting skills and child behavior. By focusing on behavior without using medication or physical treatments, it is generally safe.
The program's main goal is to support parents through online resources. No reports of negative effects have emerged from using the program, suggesting it is safe for families. Overall, it appears to be a promising option for families seeking to enhance parenting skills and support children with congenital heart disease, a condition present at birth that affects the heart.12345Why are researchers excited about this trial?
Researchers are excited about the I-InTERACT-North program because it offers a new way to support families dealing with heart disease through a virtual positive parenting approach. Unlike standard care, which typically includes only routine clinical follow-ups and assessments, I-InTERACT-North provides an interactive, stepped-care method that focuses on enhancing parenting skills to improve family dynamics and potentially the child's health outcomes. This approach takes advantage of online platforms, making it more accessible and convenient for families compared to traditional in-person support methods.
What evidence suggests that I-InTERACT-North is effective for improving parenting and child behaviour in families with children born with CHD?
Research has shown that I-InTERACT-North, which participants in this trial may receive, can improve parenting skills and reduce behavior problems in children. Studies have found that this online program teaches parents positive parenting techniques and helps manage stress, common in families with children who have congenital heart disease (CHD). Families using the program have reported improvements in interactions and children's behavior. These results suggest that I-InTERACT-North could be a helpful tool for families with children who have CHD.13467
Who Is on the Research Team?
Tricia S Williams, PhD
Principal Investigator
The Hospital for Sick Children
Are You a Good Fit for This Trial?
This trial is for parents of children aged 3-9 with congenital heart disease (CHD) who are patients at SickKids Hospital in Ontario, Canada. It aims to help these families by improving parenting skills and child behavior.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete baseline questionnaires and are randomized
Treatment
Participants receive the I-InTERACT-North virtual stepped-care positive parenting program
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- I-InTERACT-North
I-InTERACT-North is already approved in Canada for the following indications:
- Congenital Heart Disease (CHD)
- Neurodevelopmental Disorders
- Behavioral Concerns
Find a Clinic Near You
Who Is Running the Clinical Trial?
The Hospital for Sick Children
Lead Sponsor
Canadian Institutes of Health Research (CIHR)
Collaborator